Crain’s: Portal’s Portfolio Company, Cardiosense, Raises Series A $15.1 Million Round


A Chicago startup developing a wearable sensor to detect heart disease has raised funding from investors as it prepares to submit the device for regulatory approval.

Cardiosense said today that it raised $15.1 million in a funding round led by Boston-based Broadview Ventures and Durham, N.C.-based Hatteras Venture Partners. Laerdal Million Lives Fund, UnityPoint Health Ventures, and Chicago’s OSF Ventures and Portal Innovations also invested in the round.

The new funding brings Cardiosense’s total financing raised to more than $17.7 million, says co-founder and CEO Amit Gupta.

The company, which is based on research out of Northwestern University and Georgia Institute of Technology in 2020, has developed a small, multisensor, noninvasive device called the CardioTag that’s worn on the chest to detect and manage cardiovascular disease. Read the Crain’s article here: